Predictive Oncology Inc. (POAI)

Predictive Oncology Revenue

Predictive Oncology had revenue of $1.96M in the twelve months ending March 31, 2024, with 36.98% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $419.65K with 74.93% year-over-year growth. In the year 2023, Predictive Oncology had annual revenue of $1.78M with 18.24% growth.

• Revenue (ttm): $1.96M
• Revenue Growth: +36.98%
• P/S Ratio: 2.28
• Revenue / Employee: $55,996
• Employees: 35
• Market Cap: 4.47M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.78M	274.63K	18.24%
Dec 31, 2022	1.51M	84.78K	5.97%
Dec 31, 2021	1.42M	168.41K	13.45%
Dec 31, 2020	1.25M	-159.29K	-11.28%
Dec 31, 2019	1.41M	-90.00	-0.01%
Dec 31, 2018	1.41M	756.82K	115.57%
Dec 31, 2017	654.84K	198.34K	43.45%
Dec 31, 2016	456.50K	-197.86K	-30.24%
Dec 31, 2015	654.35K	-297.21K	-31.23%
Dec 31, 2014	951.56K	483.43K	103.27%
Dec 31, 2013	468.13K	279.35K	147.98%
Dec 31, 2012	188.77K	92.14K	95.34%
Dec 31, 2011	96.64K	96.35K	33,454.51%
Dec 31, 2010	288.00	-15.45K	-98.17%
Dec 31, 2009	15.74K	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.